Psychiatric NP Scope of Practice for General Psychiatry in Florida

If you’re a psychiatrist or PMHNP considering telehealth, you’ve probably asked yourself: Can I legally prescribe Adderall, benzodiazepines, or other controlled substances to patients I see online?

The short answer in 2026: Yes — but the rules are changing, and they vary dramatically by state.

Right now, federal telehealth flexibilities allow psychiatrists to prescribe Schedule II-V controlled substances via video visits without ever meeting a patient in person. That’s thanks to emergency extensions that remain in effect through December 31, 2026. But permanent DEA rules are coming, and some states have already imposed their own restrictions that are stricter than federal law.

Whether you’re evaluating a telehealth platform like Klarity Health or expanding your private practice online, understanding these regulations isn’t optional — it’s critical to your license and your patients’ safety.

Let’s break down what you need to know right now.

Current Federal Rules: DEA Telehealth Extension Through 2026

The baseline: The Ryan Haight Act (2008) requires an in-person medical evaluation before prescribing controlled substances online. However, COVID-era emergency flexibilities waived that requirement — and those waivers have been repeatedly extended.

As of January 2, 2026, the DEA and HHS announced their fourth extension of telehealth prescribing flexibilities, keeping them in place through the end of 2026. This means:

• You can prescribe Schedule II-V controlled substances via telehealth to new patients you’ve never met in person
• The encounter must use real-time audio-video technology (telephone-only generally doesn’t qualify, except for buprenorphine — more on that below)
• Standard prescribing rules still apply: appropriate evaluation, legitimate medical purpose, documented clinical reasoning
• You must be licensed and DEA-registered in the state where the patient is located

This extension was designed to prevent care disruptions while the DEA finalizes permanent rules. Translation: use this flexibility responsibly, because it won’t last forever in its current form.

What’s Coming: Permanent DEA Rules Expected in 2026

The DEA has proposed three new rules to replace the temporary extensions:

1. Buprenorphine for Opioid Use Disorder
Under the proposed rule, providers could prescribe buprenorphine via telehealth (including audio-only) for up to 6 months without an in-person visit. After six months, an in-person evaluation would be required to continue treatment. This reflects the reality that telemedicine has dramatically improved access to addiction treatment and that buprenorphine has a low abuse potential.

2. Special Telemedicine Registration
The DEA proposes creating a ‘Special Telemedicine Prescriber Registration’ that would allow qualified providers to prescribe controlled substances to new patients via telehealth without any in-person exam requirement.

Here’s the key detail for psychiatrists: Board-certified psychiatrists would be eligible for this special registration for Schedule II substances (like stimulants for ADHD). Other providers could get it for Schedule III-V, but only psychiatrists, hospice/palliative care physicians, long-term care facility physicians, and (in limited cases) pediatricians would qualify for Schedule II telehealth prescribing.

Why does this matter? It means the DEA recognizes that psychiatric providers can safely manage stimulants, benzodiazepines, and other controlled medications in a telehealth-only model — if they meet certain criteria and register properly.

The proposal also requires online telehealth platforms to register with the DEA and establishes a national Prescription Drug Monitoring Program (PDMP) to track prescriptions across state lines.

3. VA Continuity of Care Rule
A third rule addresses the VA system specifically, allowing any VA telehealth provider to prescribe controlled substances to a patient who had an in-person exam with any VA clinician. This treats the entire VA as one system for Ryan Haight purposes.

The Bottom Line on Federal Rules

• Through 2026: Telehealth prescribing of controlled substances is broadly allowed under the extension
• After 2026: Expect new requirements — likely a special registration process, possible in-person visit requirements for some treatments, and more administrative oversight
• Now: Document thoroughly, follow standard-of-care protocols, and prepare for compliance with stricter rules

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Telehealth Prescribing Rules

Federal law sets the floor, but states can (and do) impose stricter requirements. Here’s what psychiatrists need to know in key markets:

California: Telehealth-Friendly with Mandatory PDMP Checks

Bottom line: California allows telehealth prescribing of controlled substances with no special state restrictions beyond federal law.

Key requirements:

• A video visit satisfies the ‘appropriate prior exam’ requirement
• Mandatory CURES PDMP check before prescribing Schedule II-IV controlled substances for the first time, then every 4 months during ongoing treatment
• 100% e-prescribing mandate (as of January 2022) — paper scripts are essentially prohibited
• Audio-only telehealth is permitted for some services, but initial controlled substance prescribing should be done via video to meet standard of care

PMHNP practice authority: California is transitioning to full practice authority for experienced NPs. By 2026, PMHNPs with 3+ years of supervised experience can practice independently without a physician collaboration agreement.

What this means: California is a strong state for telepsychiatry. The main compliance burden is the quarterly PDMP checks and e-prescribing requirements.

Texas: Restrictive NP Rules, Chronic Pain Limitations

Bottom line: Texas allows telehealth prescribing of psychiatric controlled substances by physicians, but NPs face significant restrictions on Schedule II medications.

Key requirements:

• Video visit establishes patient-provider relationship (no in-person required for psych)
• NPs and PAs cannot prescribe Schedule II controlled substances outside hospital or hospice settings — meaning outpatient ADHD medication management must be handled by a physician
• Prescribing controlled substances for chronic pain via telehealth is prohibited without at least one in-person visit (doesn’t affect most psychiatric care)
• Mandatory PDMP check before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol

PMHNP practice authority: Texas requires physician supervision for all NP practice. No independent practice, no matter how experienced.

What this means: If you’re a PMHNP considering Texas telehealth work, you’ll need a supervising psychiatrist. If you’re a platform hiring in Texas, you need MDs available for any Schedule II prescribing. This is a major operational constraint.

Florida: Psychiatric Exception to Schedule II Ban

Bottom line: Florida has one of the most complex telehealth laws, but includes a psychiatric exception that makes telepsychiatry workable.

Key requirements:

• Florida prohibits prescribing Schedule II controlled substances via telehealth — EXCEPT for: (1) psychiatric treatment, (2) inpatient hospital care, (3) hospice care, or (4) nursing home care
• This means you can prescribe Adderall for ADHD or other Schedule II meds for mental health conditions via telehealth, but cannot prescribe them for pain management or weight loss online
• Schedules III-V (like most benzodiazepines) can be prescribed via telehealth with no special restrictions
• Out-of-state providers can register with Florida as telehealth providers without obtaining a full Florida medical license (unique to Florida), but the same prescribing restrictions apply
• Mandatory E-FORCSE PDMP check before prescribing any controlled substance to patients age 16+
• PMHNPs must have a physician collaboration agreement (no independent practice for psychiatric NPs in Florida)

What this means: Florida’s psychiatric carve-out makes telepsychiatry viable, but document the psychiatric indication clearly. If you’re out-of-state, the telehealth registration process is simpler than full licensure but still requires malpractice coverage, no disciplinary history, and other paperwork.

New York: Liberal Telehealth, Strict PDMP Requirements

Bottom line: New York allows telehealth prescribing of controlled substances with no state-level in-person requirement.

Key requirements:

• Video visit satisfies exam requirement (no in-person needed)
• Mandatory I-STOP (PMP) check before prescribing every Schedule II, III, or IV controlled substance — one of the strictest PDMP mandates in the country
• 100% e-prescribing mandate for all prescriptions (controlled and non-controlled) since 2016
• Audio-only telehealth is allowed for some mental health services (permanent post-COVID), but initial controlled substance prescribing should be video

PMHNP practice authority: Experienced NPs (3,600+ clinical hours) can practice independently. New NPs need a collaborative agreement until they hit that threshold.

What this means: New York is provider-friendly for telehealth, but the I-STOP requirement adds an administrative step to every controlled prescription. Make PDMP queries part of your workflow.

Pennsylvania: No Telehealth Statute, But Practice Allowed

Bottom line: Pennsylvania has no comprehensive telehealth law, but the medical board allows telemedicine under general practice authority.

Key requirements:

• Video visit can establish patient relationship (no in-person mandate)
• Mandatory PDMP check before prescribing opioids or benzodiazepines
• E-prescribing required for controlled substances (with limited exceptions)
• NPs need collaborative agreements with two physicians for prescriptive authority; can prescribe Schedule II for up to 30 days, Schedule III-IV for up to 90 days

What this means: Pennsylvania operates in a regulatory gray area. Telehealth is happening, but without clear statutory guidance. Document thoroughly and follow standard-of-care protocols. If you’re an NP, you need physician oversight regardless of experience level.

Illinois: Full Practice NPs, With Some Controlled Substance Limits

Bottom line: Illinois allows telehealth prescribing with no in-person requirement and offers a pathway to NP independence.

Key requirements:

• Video visit satisfies standard of care (no in-person mandate)
• Mandatory ILPMP (PDMP) check before prescribing opioids
• E-prescribing required for all controlled substances (as of January 2023)
• PMHNPs can obtain Full Practice Authority after 4,000 hours and additional training, allowing independent practice
• Even FPA NPs must have a physician consultation for ongoing Schedule II opioids or benzodiazepines (30-day script limit without consult) — though this rule’s application to stimulants is somewhat unclear

What this means: Illinois is moving toward NP independence, but with guardrails on high-risk controlled substances. The physician consultation requirement for certain Schedule II meds may or may not apply to ADHD stimulants — consult your malpractice carrier and state board for clarity.

Psychiatrist vs PMHNP Scope of Practice: What You Can Prescribe

Psychiatrists (MD/DO)

Scope: Full, independent prescriptive authority in all 50 states for all controlled substances (Schedule II-V), subject only to DEA registration and state medical licensing.

Telehealth implications: No scope-of-practice barriers. Your only constraints are licensure (must be licensed where the patient is located) and compliance with federal/state telehealth prescribing rules.

Key point: Psychiatrists face uniform rules nationwide. Once you’re licensed and DEA-registered in a state, you have full authority to prescribe as clinically appropriate.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

Scope: Highly variable by state. Ranges from full independent practice to restrictive physician supervision requirements.

State-by-state breakdown:

Telehealth implications: If you’re a PMHNP, check your state’s scope-of-practice laws before joining any telehealth platform. Some states will require the platform to provide a supervising physician. Others will restrict what you can prescribe, potentially limiting your patient panel (e.g., no ADHD patients in Texas).

Key point: Unlike psychiatrists, PMHNPs cannot assume they have the same authority everywhere. State law determines whether you can practice independently, what you can prescribe, and whether you need physician oversight.

Compliance Essentials: What Every Telehealth Prescriber Must Do

Regardless of your state or provider type, certain compliance steps are non-negotiable:

1. License and DEA Registration in Every State You Practice

Telehealth is considered to occur where the patient is located. Treat patients in five states? You need five medical licenses and five DEA registrations.

Exception: A few states (like Florida) offer out-of-state telehealth registration that’s simpler than full licensure. The Interstate Medical Licensure Compact (IMLC) also expedites licensing for physicians in member states.

2. Use Your State’s Prescription Drug Monitoring Program (PDMP)

Every priority state we’ve discussed requires PDMP checks before prescribing certain controlled substances. Timelines vary:

• California: Before first Schedule II-IV prescription, then every 4 months
• Texas: Before prescribing opioids, benzos, barbiturates, or carisoprodol
• Florida: Before any controlled substance for patients age 16+
• New York: Before every Schedule II, III, or IV prescription (strictest in the nation)
• Pennsylvania: Before prescribing opioids or benzos
• Illinois: Before prescribing opioids (encouraged for all controlled substances)

Why it matters: PDMP checks help you identify patients who may be doctor-shopping, have filled overlapping prescriptions, or are at risk of overdose. They’re also your best defense if your prescribing is ever questioned by a medical board or DEA investigator.

3. E-Prescribe All Controlled Substances

Federal Medicare Part D rules and most state laws now mandate electronic prescribing for controlled substances. Paper scripts are essentially obsolete (and often prohibited).

Your e-prescribing system must meet DEA’s Electronic Prescribing for Controlled Substances (EPCS) requirements, including two-factor authentication.

4. Document the Telehealth Encounter Thoroughly

Your documentation should demonstrate:

• Appropriate evaluation: History, mental status exam, assessment, and plan
• Clinical reasoning: Why this medication, at this dose, for this patient
• PDMP review: What you found and how it influenced your decision
• Informed consent: That the patient understands the risks/benefits of telehealth and the medication
• Follow-up plan: When you’ll reassess, what red flags to watch for

If a state medical board or DEA ever audits your prescribing, your documentation is your protection. ‘Appropriate exam’ is a legal standard — make sure your chart proves you met it.

5. Complete Mandatory Training Requirements

As of June 2023, the MATE Act requires all DEA registrants (physicians and NPs) to complete 8 hours of training on substance use disorder treatment and safe prescribing before their DEA registration renewal.

Exemptions: Board-certified addiction psychiatrists and addiction medicine specialists are exempt (their specialty training counts).

Bottom line: If you haven’t done this training yet, build it into your CME plan. It’s now a condition of maintaining your DEA registration.

The Economics of Telehealth Prescribing: Why Platforms Like Klarity Make Sense

Let’s talk about patient acquisition — because understanding telehealth regulations is pointless if you can’t build a sustainable practice.

The DIY Marketing Reality

Many psychiatrists consider building their own telehealth practice through SEO, Google Ads, Psychology Today listings, or Zocdoc. Here’s what that actually costs:

SEO: Takes 6-12 months of consistent investment ($1,500-3,000/month for agency work) before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.

Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert. Realistic cost per booked patient through PPC: $200-400+, once you factor in wasted spend on unqualified leads.

Psychology Today: Monthly subscription ($30-50) plus competing with hundreds of other providers on the same page. Conversion rates are low.

Zocdoc: Charges per booking ($35-100+ per new patient) plus monthly subscription fees. Total monthly cost adds up quickly.

The hidden costs:

• Agency/consultant fees for setup and optimization
• Staff time handling and qualifying leads
• No-show rates from cold leads (often 20-30%)
• Failed campaigns that burned through ad budget
• Months of testing before you know what works

Reality check: When you add it all up, acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ — and that assumes you’re willing to spend 6-12 months figuring it out.

The Klarity Health Model: Pay Only for Patients You See

Klarity uses a pay-per-appointment model (similar to Zocdoc) where you pay a standard listing fee per new patient lead — but with key differences:

✅ No upfront marketing spend — No $3,000-5,000/month gamble on ads that might not work
✅ Pre-qualified patients — Matched to your specialty and availability before you ever see them
✅ No wasted ad spend — You don’t pay for clicks that don’t convert
✅ Built-in telehealth infrastructure — No separate EHR or video platform costs
✅ Both insurance and cash-pay patients — Diversified revenue streams
✅ You control your schedule — Only pay when you see patients

The economic case: Instead of spending $3,000-5,000/month on marketing with uncertain results and a 6-12 month lag time, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. gambling on marketing channels.

For providers starting out or scaling: Platforms that handle patient acquisition remove the risk entirely. You can start seeing patients immediately while the platform absorbs the marketing cost and risk of acquiring them.

When DIY Makes Sense

DIY marketing can eventually be cost-effective if you have:

• The budget to sustain 6-12 months of losses before profitability
• Marketing expertise (or can afford to hire it)
• Patience to test, optimize, and iterate
• Staff to handle lead qualification and scheduling

For established providers with existing patient flow who want to add telehealth as a channel, investing in SEO or ads can make sense. But for most providers — especially those starting out or scaling — the risk/reward calculus favors platforms that guarantee patient flow.

FAQ: Telehealth Prescribing for Psychiatrists

Can I prescribe Adderall via telehealth to a new patient I’ve never met in person?

Yes, through December 31, 2026, under the federal DEA extension. You must conduct a proper video evaluation and document it thoroughly. After 2026, you may need a special DEA telemedicine registration to continue prescribing Schedule II stimulants to new patients via telehealth.

State nuances: Check your state’s rules. Florida explicitly allows this for psychiatric treatment. Texas allows it for physicians (but not NPs). All states require you to be licensed where the patient is located.

Do I need to see a patient in person before prescribing benzodiazepines via telehealth?

No, not currently. Benzodiazepines are Schedule IV controlled substances, and the federal telehealth extension allows prescribing them via video visit without an in-person exam. However, you must conduct an appropriate evaluation and check your state’s PDMP.

Clinical note: Some providers prefer an in-person visit for benzodiazepines due to abuse potential and withdrawal risks, but it’s not legally required under current federal rules.

Can PMHNPs prescribe controlled substances independently via telehealth?

It depends on the state.

• New York, California (soon), Illinois (with FPA): Yes, experienced NPs can prescribe independently
• Texas, Florida: No, NPs need physician supervision. In Texas, NPs cannot prescribe Schedule II in outpatient settings at all
• Pennsylvania: No, NPs need collaborative agreements with physicians for prescriptive authority

Check your state’s scope-of-practice laws before assuming you have independent authority.

What happens if I prescribe controlled substances via telehealth without following state rules?

Consequences can include:

• State medical board disciplinary action (license suspension or revocation)
• DEA sanctions (loss of DEA registration, civil penalties)
• Criminal prosecution in extreme cases (if prescribing falls outside legitimate medical practice)
• Malpractice liability if patient harm occurs

Bottom line: Compliance isn’t optional. If you’re unsure about your state’s rules, consult a healthcare attorney or contact your state medical board before prescribing.

How do I stay updated on DEA rule changes?

Resources:

• DEA Diversion Control website: www.deadiversion.usdoj.gov
• HHS press releases on telehealth policy
• State medical board newsletters (sign up for email alerts)
• Professional associations: American Psychiatric Association, American Association of Nurse Practitioners
• Healthcare law firms that publish telehealth updates (like Akerman, Epstein Becker Green)

Set up Google Alerts for ‘DEA telehealth’ and ‘telemedicine controlled substances’ to catch news when rules change.

Next Steps: Join a Telehealth Platform That Handles Compliance

Here’s the reality: Telehealth prescribing regulations are complex, constantly evolving, and different in every state. Even experienced psychiatrists find it overwhelming to track federal DEA rules, state medical board requirements, PDMP mandates, e-prescribing rules, scope-of-practice laws, and licensing requirements across multiple states.

Klarity Health removes that burden.

When you join Klarity’s provider network, you get:

✅ Compliance infrastructure built-in — Telehealth platform that meets federal and state requirements
✅ State-specific guidance — Support team that understands licensing and prescribing rules in your states
✅ Qualified patient flow — No wasted time marketing or chasing leads
✅ Both insurance and cash-pay patients — Flexibility to serve the patients you want to see
✅ Pay-per-appointment model — No upfront costs, no monthly subscriptions, you only pay when you see patients

For psychiatrists: Full prescriptive authority across all states where you’re licensed, with a patient panel that matches your expertise.

For PMHNPs: Clear scope-of-practice guidelines in each state, with physician collaboration arrangements built-in where required by law.

The bottom line: You focus on patient care. Klarity handles the rest — patient acquisition, compliance infrastructure, telehealth technology, and billing.

Ready to explore telehealth without the compliance headaches? Learn more about joining Klarity Health’s provider network and start seeing patients on your schedule, with full regulatory support.

Sources

1. U.S. Department of Health and Human Services. ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ Press Release, January 2, 2026. www.hhs.gov

2. U.S. Drug Enforcement Administration. ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Vital Care.’ Press Release, January 16, 2025. www.dea.gov

3. Akerman LLP. ‘Harmonizing Federal and Florida Laws on Prescribing Controlled Substances Through Telehealth.’ Legal Bulletin, March 2023. www.akerman.com

4. Texas Medical Board. ‘Prescriptive Authority and Supervision FAQs.’ Regulatory Guidance, Updated 2024. www.tmb.texas.gov

5. Substance Abuse and Mental Health Services Administration (SAMHSA). ‘Elimination of the DATA Waiver (X-Waiver) Requirement.’ Updated 2023. www.samhsa.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=WASHINGTON%E2%80%94JANUARY%202%2C%202026%E2%80%94The%20U,while%20permanent%20rules%20are%20finalized
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=Expansion%20of%20Buprenorphine%20Treatment%20via,Telemedicine%20Encounter
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=For%20the%20first%20time%20online,being%20of%20patients
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=In%20developing%20these%20rules%2C%20DEA,person%20by%20the%20medical%20provider
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=telehealth%20to%20prescribe%20schedules%20III,one%20of%20the%20following%20categories
• https://www.jdsupra.com/legalnews/states-and-feds-signal-big-changes-to-9301791/#:~:text=of%20Ohio%E2%80%99s%20new%20telehealth%20prescribing,substance%20use%20disorder%20treatment%2C%20is
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=No%20special%20registration%20is%20required,the%20State%20to%20do%20so
• https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state#:~:text=,start%20their%20own%20medical%20practices